{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:00:15Z","timestamp":1781712015695,"version":"3.54.5"},"reference-count":138,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"am","delay-in-days":507,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.semnephrol.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T06:23:32Z","timestamp":1653287012000},"page":"29-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach"],"prefix":"10.1016","volume":"42","author":[{"given":"Francesca","family":"Zanoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Khairallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kiryluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Batal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.semnephrol.2022.01.005_bib0001","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2022.01.005_bib0002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: kidney","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2022.01.005_bib0003","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"issue":"3 Suppl 1","key":"10.1016\/j.semnephrol.2022.01.005_bib0005","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2018.01.002","article-title":"US Renal Data System 2017 Annual data report: epidemiology of kidney disease in the United States","volume":"71","author":"Saran","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0006","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12882-018-0908-3","article-title":"What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients","volume":"19","author":"Shi","year":"2018","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0007","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.semnephrol.2022.01.005_bib0008","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/TXD.0000000000000597","article-title":"HLA matching trumps donor age: donor-recipient pairing characteristics that impact long-term success in living donor kidney transplantation in the era of paired kidney exchange","volume":"2","author":"Milner","year":"2016","journal-title":"Transplant Direct"},{"issue":"suppl 3","key":"10.1016\/j.semnephrol.2022.01.005_bib0009","article-title":"Acute rejection and late renal transplant failure: risk factors and prognosis","volume":"19","author":"Pallard\u00f3 Mateu","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2022.01.005_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14124","article-title":"OPTN\/SRTR 2015 annual data report: kidney","volume":"17","author":"Hart","year":"2017","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0011","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"issue":"1 Suppl 1","key":"10.1016\/j.semnephrol.2022.01.005_bib0012","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US Renal Data System 2019 annual data report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0014","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.kint.2016.08.030","article-title":"Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation","volume":"91","author":"Cosio","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2017.03.015","article-title":"Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes","volume":"92","author":"Allen","year":"2017","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2022.01.005_bib0016","doi-asserted-by":"crossref","first-page":"e13738","DOI":"10.1111\/ctr.13738","article-title":"The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation","volume":"33","author":"Singh","year":"2019","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0017","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.ajkd.2018.09.002","article-title":"Kidney transplantation in C3 glomerulopathy: a case series","volume":"73","author":"Regunathan-Shenk","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.semnephrol.2022.01.005_bib0018","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1097\/TP.0000000000001056","article-title":"Recurrent membranous nephropathy after kidney transplantation: treatment and long-term implications","volume":"100","author":"Grupper","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0019","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2215\/CJN.08970719","article-title":"Recurrence of FSGS after kidney transplantation in adults","volume":"15","author":"Uffing","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0021","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/ndt\/gfn014","article-title":"IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes","volume":"23","author":"Haas","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0022","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.ajkd.2012.02.326","article-title":"Risk stratification of patients with IgA nephropathy","volume":"59","author":"Barbour","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0023","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/01.ASN.0000068460.37369.DC","article-title":"Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial","volume":"14","author":"Praga","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2022.01.005_bib0024","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1093\/ndt\/gfp356","article-title":"Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy","volume":"24","author":"Manno","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40620-016-0265-x","article-title":"IgA nephropathy and infections","volume":"29","author":"Rollino","year":"2016","journal-title":"J Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2022.01.005_bib0026","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0027","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ki.2015.252","article-title":"New developments in the genetics, pathogenesis, and therapy of IgA nephropathy","volume":"88","author":"Magistroni","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0028","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10157-018-1582-2","article-title":"Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis","volume":"23","author":"Suzuki","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0029","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.ackd.2019.12.004","article-title":"Complement in IgA nephropathy: the role of complement in the pathogenesis, diagnosis, and future management of IgA nephropathy","volume":"27","author":"Medjeral-Thomas","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11","key":"10.1016\/j.semnephrol.2022.01.005_bib0030","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.ekir.2019.07.015","article-title":"Epidemiology and pathophysiology of glomerular C4d staining in native kidney biopsies","volume":"4","author":"Drachenberg","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0031","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2022.01.005_bib0032","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","article-title":"Evaluating a new international risk-prediction tool in IgA nephropathy","volume":"179","author":"Barbour","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0033","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0272-6386(88)80021-0","article-title":"Worldwide perspective of IgA nephropathy","volume":"12","author":"Levy","year":"1988","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0034","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1056\/NEJM198501243120403","article-title":"Familial IgA nephropathy. Evidence of an inherited mechanism of disease","volume":"312","author":"Julian","year":"1985","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.semnephrol.2022.01.005_bib0035","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1681\/ASN.2010010076","article-title":"HLA has strongest association with IgA nephropathy in genome-wide analysis","volume":"21","author":"Feehally","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0036","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng.787","article-title":"Genome-wide association study identifies susceptibility loci for IgA nephropathy","volume":"43","author":"Gharavi","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0037","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ng.1047","article-title":"A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy","volume":"44","author":"Yu","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0038","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1038\/ncomms8270","article-title":"Identification of new susceptibility loci for IgA nephropathy in Han Chinese","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.semnephrol.2022.01.005_bib0039","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12882-018-1135-7","article-title":"Recurrent glomerulonephritis following renal transplantation and impact on graft survival","volume":"19","author":"Jiang","year":"2018","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0136","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000519834","volume":"2","author":"Kavanagh","year":"2022","journal-title":"Glomerular Diseases"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0137","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2215\/CJN.00910121","article-title":"Recurrence of IgA Nephropathy after Kidney Transplantation in Adults","volume":"16","author":"Uffing","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0041","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3389\/fimmu.2019.01332","article-title":"Immunoglobulin A nephropathy. Recurrence after renal transplantation","volume":"10","author":"Moroni","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0042","first-page":"309","article-title":"Recurrent mesangial IgA nephritis following renal transplantation","volume":"9","author":"Odum","year":"1994","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0043","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/ndt\/gfr664","article-title":"IgA nephropathy recurs early in the graft when assessed by protocol biopsy","volume":"27","author":"Ortiz","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0044","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.transproceed.2016.08.011","article-title":"Recurrent IgA nephropathy after kidney transplantation","volume":"48","author":"Nijim","year":"2016","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000453081","article-title":"Predicting post-transplant recurrence of IgA nephropathy: the importance of crescents","volume":"45","author":"Avasare","year":"2017","journal-title":"Am J Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0046","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1600-6143.2011.03667.x","article-title":"Steroids and recurrent IgA nephropathy after kidney transplantation","volume":"11","author":"Clayton","year":"2011","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0047","doi-asserted-by":"crossref","first-page":"e13207","DOI":"10.1111\/ctr.13207","article-title":"Recurrent IgA nephropathy after renal transplantation and steroid withdrawal","volume":"32","author":"Di Vico","year":"2018","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0048","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1681\/ASN.2016060670","article-title":"Prognostic value of serum biomarkers of autoimmunity for recurrence of IgA nephropathy after kidney transplantation","volume":"28","author":"Berthoux","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0049","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ki.2015.158","article-title":"Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes","volume":"88","author":"Berthelot","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1432-2277.2009.00966.x","article-title":"Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy","volume":"23","author":"Han","year":"2010","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0051","first-page":"279","article-title":"Favorable outcome of renal transplantation in patients with IgA nephropathy","volume":"56","author":"Andresdottir","year":"2001","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0052","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.tp.0000230131.66971.45","article-title":"Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches","volume":"82","author":"McDonald","year":"2006","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0053","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.tp.0000179150.84803.56","article-title":"Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry data","volume":"80","author":"Andresdottir","year":"2005","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0054","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molimm.2015.07.003","article-title":"Membranous nephropathy: a fairy tale for immunopathologists, nephrologists and patients","volume":"68","author":"Ronco","year":"2015","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0270-9295(03)00049-4","article-title":"Diagnosis and natural course of membranous nephropathy","volume":"23","author":"Glassock","year":"2003","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0056","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"10.1016\/j.semnephrol.2022.01.005_bib0057","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0058","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery","volume":"96","author":"van de Logt","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0059","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.kint.2017.01.012","article-title":"B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab","volume":"92","author":"Rosenzwajg","year":"2017","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0060","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0061","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","article-title":"Membranous nephropathy: a journey from bench to bedside","volume":"68","author":"Francis","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0062","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0063","article-title":"New 'antigens' in membranous nephropathy","author":"Sethi","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0064","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2013060576","article-title":"Can genetics risk-stratify patients with membranous nephropathy?","volume":"24","author":"Bomback","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2022.01.005_bib0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0066","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ndt\/gfw001","article-title":"Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies","volume":"32","author":"Sekula","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2022.01.005_bib0067","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ndt\/gfv399","article-title":"PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians","volume":"31","author":"Ramachandran","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0068","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","article-title":"The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis","volume":"11","author":"Xie","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0069","first-page":"144","article-title":"Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors","volume":"50","author":"Cosyns","year":"1998","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0070","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0272-6386(12)80685-8","article-title":"The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review","volume":"24","author":"Josephson","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0071","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1600-6143.2008.02237.x","article-title":"Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study","volume":"8","author":"Dabade","year":"2008","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2022.01.005_bib0072","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1111\/j.1600-6143.2009.02851.x","article-title":"Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0073","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.04120609","article-title":"Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation","volume":"5","author":"Sprangers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0074","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2020.01.009","article-title":"Association of HLA typing and alloimmunity with posttransplantation membranous nephropathy: a multicenter case series","volume":"76","author":"Batal","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMc1003066","article-title":"PLA2R autoantibodies and recurrent membranous nephropathy after transplantation","volume":"363","author":"Stahl","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0076","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/TP.0000000000000630","article-title":"Antiphospholipase A2 receptor antibody levels predict the risk of posttransplantation recurrence of membranous nephropathy","volume":"99","author":"Quintana","year":"2015","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.semnephrol.2022.01.005_bib0077","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00007890-199505150-00009","article-title":"Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients","volume":"59","author":"Couchoud","year":"1995","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0078","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-6143.2011.03818.x","article-title":"Increased risk of recurrence of membranous nephropathy after related donor kidney transplantation","volume":"12","author":"Andresdottir","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0079","article-title":"HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients","author":"Berchtold","year":"2020","journal-title":"Kidney Int"},{"issue":"25","key":"10.1016\/j.semnephrol.2022.01.005_bib0080","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D'Agati","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0081","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/snep.2003.50025","article-title":"Trends in the epidemiology of focal segmental glomerulosclerosis","volume":"23","author":"Kitiyakara","year":"2003","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0082","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.2017090958","article-title":"Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach","volume":"29","author":"De Vriese","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0083","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","article-title":"Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0084","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12882-020-01797-7","article-title":"Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis","volume":"21","author":"Hansrivijit","year":"2020","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0085","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2022.01.005_bib0086","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","article-title":"Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis","volume":"5","author":"McCarthy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"256","key":"10.1016\/j.semnephrol.2022.01.005_bib0087","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0088","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0138","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0089","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ckj\/sfu100","article-title":"Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations","volume":"7","author":"Sethi","year":"2014","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0090","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1046\/j.1523-1755.1999.00769.x","article-title":"Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study","volume":"56","author":"Laurinavicius","year":"1999","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0091","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D'Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.semnephrol.2022.01.005_bib0092","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","article-title":"Genetic testing in steroid-resistant nephrotic syndrome: when and how?","volume":"31","author":"Lovric","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0093","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2215\/CJN.08750718","article-title":"Integration of genetic testing and pathology for the diagnosis of adults with FSGS","volume":"14","author":"Yao","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0094","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ki.2012.349","article-title":"Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis","volume":"83","author":"Barua","year":"2013","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2022.01.005_bib0095","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1681\/ASN.2017111185","article-title":"Transethnic, genome-wide analysis reveals immune-related risk alleles and phenotypic correlates in pediatric steroid-sensitive nephrotic syndrome","volume":"29","author":"Debiec","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0096","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.kint.2020.05.029","article-title":"Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome","volume":"98","author":"Jia","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0097","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/ajkd.2001.21311","article-title":"Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States","volume":"37","author":"Abbott","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.semnephrol.2022.01.005_bib0098","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2215\/CJN.03060316","article-title":"Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis","volume":"11","author":"Francis","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0099","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0012.2008.00908.x","article-title":"Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function","volume":"23","author":"Sener","year":"2009","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2022.01.005_bib0100","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/TP.0b013e31819f12be","article-title":"Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence","volume":"87","author":"Hickson","year":"2009","journal-title":"Transplantation"},{"issue":"Suppl 6","key":"10.1016\/j.semnephrol.2022.01.005_bib0101","article-title":"Recurrent disease in renal transplants","volume":"18","author":"Newstead","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0102","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00467-001-0759-0","article-title":"Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation","volume":"17","author":"Fujisawa","year":"2002","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2022.01.005_bib0103","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MOT.0000000000000718","article-title":"Genetic background and transplantation outcomes: insights from genome-wide association studies","volume":"25","author":"Zanoni","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0104","first-page":"106","article-title":"Collapsing glomerulopathy\u2013a new pattern of renal injury","volume":"19","author":"Laurinavicius","year":"2002","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ckj\/sfx029","article-title":"Collapsing glomerulopathy: a 30-year perspective and single, large center experience","volume":"10","author":"Nicholas Cossey","year":"2017","journal-title":"Clin Kidney J"},{"issue":"10","key":"10.1016\/j.semnephrol.2022.01.005_bib0106","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1681\/ASN.2006030225","article-title":"Collapsing glomerulopathy","volume":"17","author":"Albaqumi","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2022.01.005_bib0107","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1681\/ASN.2009010122","article-title":"Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells","volume":"20","author":"Smeets","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0108","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1681\/ASN.2013070687","article-title":"Extensive podocyte loss triggers a rapid parietal epithelial cell response","volume":"25","author":"Hakroush","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0109","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jclinpath-2020-206517","article-title":"Gene of the month: APOL1","volume":"73","author":"Raghubeer","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0111","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021119-034345","article-title":"APOL1 and kidney disease: from genetics to biology","volume":"82","author":"Friedman","year":"2020","journal-title":"Annu Rev Physiol"},{"issue":"11","key":"10.1016\/j.semnephrol.2022.01.005_bib0112","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0113","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1681\/ASN.2020060802","article-title":"Kidney biopsy findings in patients with COVID-19","volume":"31","author":"Kudose","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0114","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0116","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.kint.2018.06.024","article-title":"Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts","volume":"94","author":"Santoriello","year":"2018","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.semnephrol.2022.01.005_bib0117","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/00007890-199805150-00009","article-title":"De novo collapsing glomerulopathy in renal allografts","volume":"65","author":"Meehan","year":"1998","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0118","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0272-6386(99)70216-7","article-title":"Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations","volume":"33","author":"Stokes","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.semnephrol.2022.01.005_bib0119","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/ndt\/gfl225","article-title":"Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants","volume":"21","author":"Swaminathan","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2022.01.005_bib0120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2009.07.014","article-title":"Glomerular collapse associated with subtotal renal infarction in kidney transplant recipients with multiple renal arteries","volume":"55","author":"Canaud","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.semnephrol.2022.01.005_bib0121","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/hupa.2002.124333","article-title":"Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes","volume":"33","author":"Nadasdy","year":"2002","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0122","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/ajt.13748","article-title":"APOL1 polymorphisms in a deceased donor and early presentation of collapsing glomerulopathy and focal segmental glomerulosclerosis in two recipients","volume":"16","author":"Shah","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0123","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3389\/fimmu.2019.01944","article-title":"Recurrent and de novo glomerulonephritis after kidney transplantation","volume":"10","author":"Lim","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0124","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5500\/wjt.v7.i6.285","article-title":"De novo glomerular diseases after renal transplantation: how is it different from recurrent glomerular diseases?","volume":"7","author":"Abbas","year":"2017","journal-title":"World J Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0125","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/TP.0000000000003012","article-title":"The causes of kidney allograft failure: more than alloimmunity. A viewpoint article","volume":"104","author":"Van Loon","year":"2020","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.semnephrol.2022.01.005_bib0126","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.humpath.2015.06.012","article-title":"Non-immunoglobulin A mesangial immune complex glomerulonephritis in kidney transplants","volume":"46","author":"Giannico","year":"2015","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0127","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/TP.0000000000001068","article-title":"Immune complex-type deposits in the Fischer-344 to Lewis rat model of renal transplantation and a subset of human transplant glomerulopathy","volume":"100","author":"Grau","year":"2016","journal-title":"Transplantation"},{"issue":"26","key":"10.1016\/j.semnephrol.2022.01.005_bib0128","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2022.01.005_bib0129","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.ajkd.2014.09.001","article-title":"Membranous nephropathy as a manifestation of graft-versus-host disease: association with HLA antigen typing, phospholipase A2 receptor, and C4d","volume":"64","author":"Byrne-Dugan","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.semnephrol.2022.01.005_bib0130","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ekir.2020.01.022","article-title":"Histologic case definition of an atypical glomerular immune-complex deposition following kidney transplantation","volume":"5","author":"Chin","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0131","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ekir.2020.12.028","article-title":"The association between post-kidney transplant de novo glomerulonephritis and alloimmunity","volume":"6","author":"Khairallah","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1016\/j.semnephrol.2022.01.005_bib0132","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/TP.0b013e31828a947b","article-title":"Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy","volume":"95","author":"Larsen","year":"2013","journal-title":"Transplantation"},{"issue":"37","key":"10.1016\/j.semnephrol.2022.01.005_bib0133","doi-asserted-by":"crossref","first-page":"e4809","DOI":"10.1097\/MD.0000000000004809","article-title":"HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy","volume":"95","author":"Wen","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.semnephrol.2022.01.005_bib0134","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-6143.2001.10212.x","article-title":"Hepatitis C virus infection and de novo glomerular lesions in renal allografts","volume":"1","author":"Cruzado","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2022.01.005_bib0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.humpath.2017.10.012","article-title":"De novo immune complex deposition in kidney allografts: a series of 32 patients","volume":"71","author":"Lloyd","year":"2018","journal-title":"Hum Pathol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929522000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929522000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:39:49Z","timestamp":1759448389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929522000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":138,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0270929522000055"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2022.01.005","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}